These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15906288)

  • 1. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation.
    Quarles CC; Ward BD; Schmainda KM
    Magn Reson Med; 2005 Jun; 53(6):1307-16. PubMed ID: 15906288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
    Sarraf M; Perles-Barbacaru AT; Nissou MF; van der Sanden B; Berger F; Lahrech H
    Magn Reson Med; 2015 Mar; 73(3):1005-14. PubMed ID: 24733739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI.
    Quarles CC; Schmainda KM
    Magn Reson Med; 2007 Apr; 57(4):680-7. PubMed ID: 17390352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: implications for the evaluation of tumor angiogenesis.
    Kim YR; Rebro KJ; Schmainda KM
    Magn Reson Med; 2002 Jun; 47(6):1110-20. PubMed ID: 12111957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake.
    van der Sanden BP; Rozijn TH; Rijken PF; Peters HP; Heerschap A; van der Kogel AJ; Bovée WM
    J Cereb Blood Flow Metab; 2000 May; 20(5):861-70. PubMed ID: 10826537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of glioma microcirculation and tissue features using intravoxel incoherent motion magnetic resonance imaging in a rat brain model.
    Iima M; Reynaud O; Tsurugizawa T; Ciobanu L; Li JR; Geffroy F; Djemai B; Umehana M; Le Bihan D
    Invest Radiol; 2014 Jul; 49(7):485-90. PubMed ID: 24619211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vessel size imaging using dual contrast agent injections.
    Hsu YY; Yang WS; Lim KE; Liu HL
    J Magn Reson Imaging; 2009 Nov; 30(5):1078-84. PubMed ID: 19856441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions.
    Kleppestø M; Larsson C; Groote I; Salo R; Vardal J; Courivaud F; Bjørnerud A
    J Magn Reson Imaging; 2014 May; 39(5):1314-9. PubMed ID: 24123598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions.
    Singh A; Haris M; Rathore D; Purwar A; Sarma M; Bayu G; Husain N; Rathore RK; Gupta RK
    J Magn Reson Imaging; 2007 Oct; 26(4):871-80. PubMed ID: 17896358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.
    Quarles CC; Krouwer HG; Rand SD; Schmainda KM
    Technol Cancer Res Treat; 2005 Jun; 4(3):245-9. PubMed ID: 15896079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
    Pickup S; Chawla S; Poptani H
    Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose.
    Pathak AP; Rand SD; Schmainda KM
    J Magn Reson Imaging; 2003 Oct; 18(4):397-403. PubMed ID: 14508775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.